Stem Cell Research & Therapy Journal Citation Rate 2026
1757-6512
Springer Nature
GB
Q1 Quartile Open Access Top Tier
About Stem Cell Research & Therapy
Stem Cell Research & Therapy (SCRT) is a peer-reviewed academic journal, published by Springer Nature in GB, catalogued under ISSN 1757-6512. As of 2026, it has a 2024 2-Year Citation Rate (OpenAlex) of 64.50 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access.
Stem Cell Research & Therapy Citation Rate 2026 — In Context
Stem Cell Research & Therapy has a 2024 2-Year Citation Rate (OpenAlex) of 64.50, placing it in the Q1 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, Stem Cell Research & Therapy makes all articles freely available to readers.
Researchers looking to publish in Stem Cell Research & Therapy should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Stem Cell Research & Therapy against similar journals in the field, use our journal comparison tool.
| ISSN (Print) | 1757-6512 |
|---|---|
| Publisher | Springer Nature |
| Country | United Kingdom |
| APC / Cost | Inquire with Publisher |
In-depth profile & metrics
Stem Cell Research & Therapy is published by Springer Nature and based in United Kingdom. It publishes on an open-access basis.
Its citation rate has held broadly steady over the last 1 years, from 61.275 (2023) to 64.500 (2024).
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Stem Cell Research & Therapy
Live Indexing Status
Updated March 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
The impact factor has remained stable over the last 1 years (from 61.275 to 64.500), reflecting consistent citation performance.
Citation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2024 | 64.500 | 2-Year Mean Citedness (OpenAlex) |
| 2023 | 61.275 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Research Highlights
Recently published high-impact papers in this journal:
-
Nanofiber-reinforced ECM-based bioink for hybrid biofabrication of adventitia-mimetic anisotropic vascular constructs
Zhiyuan She, Yingqian Zhou, Shan Mou • 2026
Explore More Journals
Metadata
Last updated: Mar 15, 2026
Updated by: system
Get weekly updates
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.